DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY

Scope & Guideline

Navigating the Complexities of Drug Formulation and Manufacturing

Introduction

Immerse yourself in the scholarly insights of DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN0363-9045
PublisherTAYLOR & FRANCIS LTD
Support Open AccessNo
CountryUnited States
TypeJournal
Converge1974, from 1976 to 2024
AbbreviationDRUG DEV IND PHARM / Drug Dev. Ind. Pharm.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND

Aims and Scopes

The journal 'Drug Development and Industrial Pharmacy' focuses on advancing the field of pharmaceutical sciences with an emphasis on drug formulation, delivery systems, and industrial practices. It aims to bridge the gap between laboratory research and practical applications in the pharmaceutical industry.
  1. Drug Formulation and Delivery Systems:
    The journal emphasizes innovative drug formulation strategies, particularly those involving nanotechnology, to enhance drug solubility, stability, and bioavailability. This includes the development of nanoemulsions, liposomes, and polymeric nanoparticles for various therapeutic applications.
  2. Quality by Design (QbD) Approaches:
    A core focus is on the application of QbD principles in pharmaceutical development, which ensures that the quality of drug products is built into the formulation process, thereby enhancing product reliability and compliance with regulatory standards.
  3. Pharmacokinetics and Pharmacodynamics:
    Research published in the journal often explores the pharmacokinetic and pharmacodynamic profiles of novel formulations, providing insights into their efficacy and safety in clinical settings.
  4. Natural Products and Phytopharmaceuticals:
    The journal also highlights the use of natural products and phytochemicals in drug development, exploring their potential therapeutic effects and mechanisms of action.
  5. Analytical Methods in Drug Development:
    A significant emphasis is placed on the development and validation of analytical techniques for the characterization of drug formulations, ensuring their quality and performance through rigorous testing.
The journal has seen a rise in interest in several emerging themes, reflecting the latest advancements in drug development and industrial pharmacy practices. These trends highlight the journal's commitment to addressing contemporary challenges in the pharmaceutical field.
  1. Nanotechnology in Drug Delivery:
    There is a significant increase in research focusing on nanotechnology applications in drug delivery systems, including the use of nanocarriers, nanocrystals, and nanoemulsions to improve the pharmacokinetic profiles of drugs.
  2. Personalized Medicine and Targeted Therapies:
    Emerging themes include personalized medicine approaches that cater to individual patient needs, particularly in oncology and chronic diseases, where targeted therapies are becoming more prevalent.
  3. Regenerative Medicine and Drug Delivery Systems:
    The journal is increasingly publishing studies related to regenerative medicine, particularly involving novel drug delivery systems that enhance tissue repair and regeneration.
  4. Sustainable and Green Chemistry:
    There is a growing focus on sustainable practices in drug development, including the use of green chemistry principles to minimize environmental impact and improve the safety of pharmaceutical processes.
  5. Theranostics:
    The integration of therapeutic and diagnostic approaches, or theranostics, is gaining traction, with research exploring how combined therapies can enhance treatment efficacy and patient outcomes.

Declining or Waning

As the field of drug development evolves, certain themes within the journal's scope appear to be declining in prominence. These waning themes reflect shifts in research focus and the increasing prioritization of novel methodologies and technologies.
  1. Traditional Drug Formulation Techniques:
    There is a noticeable decrease in publications focusing on conventional drug formulation methods, such as simple mixing or granulation techniques, as the field shifts towards more sophisticated and technologically advanced approaches.
  2. Single-drug Formulations:
    Research on single-drug formulations is becoming less common, with a growing trend towards combination therapies and multi-drug delivery systems that can enhance treatment efficacy and reduce side effects.
  3. Basic Pharmacological Studies:
    While basic pharmacological studies remain important, there is a decline in the number of publications focusing solely on these aspects without integration into formulation development or delivery systems, as the journal increasingly prioritizes translational research.

Similar Journals

ACTA POLONIAE PHARMACEUTICA

Empowering Scholars in the Quest for Drug Discovery
Publisher: POLSKIE TOWARZYSTWO FARMACEUTYCZNEISSN: 0001-6837Frequency: 4 issues/year

ACTA POLONIAE PHARMACEUTICA is a well-established peer-reviewed journal published by Polskie Towarzystwo Farmaceutyczne, dedicated to the field of pharmaceutical sciences and pharmacology. With a rich history dating back to 1951, this journal serves as a vital platform for disseminating cutting-edge research and developments in pharmaceutical technology, drug development, and therapeutic therapies. Although it currently operates under a subscription model, its commitment to scientific rigor has earned it a respectable impact factor, placing it in the Q3 and Q4 quartiles respectively for Pharmaceutical Science and Pharmacology as of 2023. Researchers and practitioners alike will find value in its comprehensive coverage of essential topics, as well as its diverse range of contributions from both established and emerging scholars in the field. With its address located in the heart of Warsaw, Poland, ACTA POLONIAE PHARMACEUTICA aims to further bridge the gap between academia and industry, paving the way for innovation in drug discovery and therapeutic applications.

Istanbul Journal of Pharmacy

Uniting scholars to elevate pharmaceutical discourse.
Publisher: ISTANBUL UNIV, FAC PHARMACYISSN: Frequency: 3 issues/year

Istanbul Journal of Pharmacy, published by Istanbul University, Faculty of Pharmacy, is a pivotal platform dedicated to the advancement of pharmaceutical sciences and technology. This journal serves as a vital resource for researchers, professionals, and students alike, seeking to disseminate cutting-edge research, reviews, and innovative methodologies within the pharmaceutical discipline. With a commitment to open access, the journal aims to foster a collaborative environment that promotes information sharing and scholarly discourse. The Istanbul Journal of Pharmacy invites submissions that delve into diverse topics ranging from drug formulation to pharmacokinetics, ensuring that readers are equipped with the latest insights and discoveries in the field. This journal is positioned to enhance scientific communication within the pharmaceutical community and support the continuous evolution of pharmacy practice and education globally.

JOURNAL OF PHARMACEUTICAL SCIENCES

Pioneering insights in pharmaceutical sciences since 1961.
Publisher: ELSEVIER SCIENCE INCISSN: 0022-3549Frequency: 12 issues/year

The JOURNAL OF PHARMACEUTICAL SCIENCES, published by ELSEVIER SCIENCE INC, stands as a cornerstone in the field of pharmaceutical sciences, offering a platform for innovative research and advancements since its inception in 1961. With an impressive Scopus Rank of #36 out of 183 in the Pharmaceutical Science category, this journal is recognized for its commitment to disseminating high-quality, peer-reviewed studies that significantly contribute to the realms of pharmacology, toxicology, and pharmaceutics. Holding a 2023 Q2 category quartile, it attracts a diverse readership encompassing researchers, industry professionals, and students eager to advance their understanding and expertise. While the journal is not open access, it ensures valuable insights in every issue, making it an essential resource for those dedicated to the evolving landscape of pharmaceutical research. With an impact factor that reflects its relevance and influence, the JOURNAL OF PHARMACEUTICAL SCIENCES continues to shape the discourse in its domain, fostering innovation and collaboration among scholars worldwide.

Pakistan Journal of Pharmaceutical Sciences

Delivering critical studies that shape the pharmaceutical landscape.
Publisher: UNIV KARACHIISSN: 1011-601XFrequency: 4 issues/year

Pakistan Journal of Pharmaceutical Sciences, published by the University of Karachi, serves as a vital platform for advancing research in the field of pharmaceutical sciences. With a strong commitment to disseminating innovative findings and critical studies since its inception in 1995, the journal focuses on a wide array of topics including pharmacology, toxicology, and pharmaceutics. With an ISSN of 1011-601X, it holds a reputable position within the academic community, reflecting its Q3 category ranking in Pharmaceutical Science as of 2023. While the journal is currently not designated as Open Access, it remains accessible through institutional subscriptions, ensuring that both emerging and established researchers can contribute to and benefit from its scholarly content. This publication not only promotes scientific dialogue but also aims to bridge the gap between academia and industry, appealing to a diverse audience of researchers, professionals, and students seeking to stay informed about the latest advancements and trends in pharmaceutical research.

Ars Pharmaceutica

Fostering collaboration for transformative pharmaceutical insights.
Publisher: UNIV GRANADA, EDITORIALISSN: 0004-2927Frequency: 4 issues/year

Ars Pharmaceutica is a distinguished open-access journal published by UNIV GRANADA, EDITORIAL, that has been at the forefront of pharmaceutical sciences since its establishment. With ISSN 0004-2927 and E-ISSN 2340-9894, this journal aims to disseminate high-quality research in pharmacology, toxicology, and pharmaceutics, contributing to the advancement of the field. With a historical scope that spans from 1980 to 2017, it has played a pivotal role in shaping the discourse surrounding pharmaceutical science and its intersection with the arts and humanities. Although currently ranked within the 13th percentile in Scopus for Pharmaceutical Science and the 11th percentile for History and Philosophy of Science, Ars Pharmaceutica continues to uphold its commitment to academic excellence and innovation. By providing a platform for open-access research, it encourages collaboration and knowledge sharing among researchers, professionals, and students, thus enhancing the broader understanding of pharmaceutical developments and their societal implications.

PHARMACIA

Advancing pharmaceutical knowledge for a healthier tomorrow.
Publisher: PENSOFT PUBLISHERSISSN: 0428-0296Frequency: 4 issues/year

PHARMACIA is a distinguished open-access journal, published by PENSOFT PUBLISHERS, that has been a pivotal platform for advancing the field of pharmaceutical sciences since 2007. This journal, with ISSN 0428-0296 and E-ISSN 2603-557X, is based in Bulgaria and continues to publish high-quality research and reviews relevant to pharmacy, pharmacology, and toxicology. Recognized in the Q3 category for Pharmaceutical Sciences and Pharmacology (medical), as well as Q2 in Pharmacy according to the latest rankings, PHARMACIA is celebrated for its commitment to fostering knowledge dissemination and innovation in drug development, therapeutic approaches, and pharmacological research. With a Scopus rank of #17 in Pharmacy and recognition in various health professions, the journal attracts contributions from researchers, professionals, and students seeking to impact the pharmaceutical landscape. Its convenient open-access format ensures that articles are readily available to a global audience, encouraging collaboration and advancement in the life sciences.

Turkish Journal of Pharmaceutical Sciences

Exploring the Frontiers of Molecular Medicine
Publisher: GALENOS PUBL HOUSEISSN: 1304-530XFrequency: 6 issues/year

The Turkish Journal of Pharmaceutical Sciences, an esteemed publication by GALENOS PUBL HOUSE, has been a prominent platform for research and innovation in the fields of Pharmaceutical Sciences and Molecular Medicine since its inception as an Open Access journal in 2004. Based in Turkey, this journal serves as a vital resource for researchers, professionals, and students keen on exploring the latest advancements in drug development, pharmacology, and therapeutic innovations. With an ISSN of 1304-530X and an E-ISSN of 2148-6247, the journal is indexed in leading databases and has demonstrated strong rankings in the Scopus index, notably securing the second quartile in Pharmaceutical Sciences. Furthermore, it fosters academic collaboration and knowledge dissemination by making its content freely accessible. The journal aims to inspire groundbreaking research, providing an important academic forum for the dissemination of valuable insights that impact the pharmaceutical sector and contribute to global health.

International Journal of Pharmaceutics-X

Empowering researchers to shape the future of pharmaceuticals.
Publisher: ELSEVIERISSN: Frequency: 1 issue/year

International Journal of Pharmaceutics-X is a premier open access journal published by Elsevier, dedicated to advancing knowledge and research in the field of pharmaceutical sciences. Launched in 2019, this journal has quickly ascended to the Q1 category in the 2023 Category Quartiles, reflecting its high impact and the quality of research it promotes. With a current Scopus ranking of #49 out of 183 in the Pharmacology, Toxicology and Pharmaceutics category, this journal occupies the 73rd percentile, showcasing its significant influence within the scholarly community. Emphasizing innovative research and novel applications, the International Journal of Pharmaceutics-X offers a platform for researchers, professionals, and students to disseminate their findings, making crucial contributions to the global pharmaceutical landscape. The journal is based in the Netherlands, presenting a vibrant hub for scientific discourse and collaboration in a rapidly evolving field.

Indonesian Journal of Pharmacy

Connecting global minds in the pursuit of pharmaceutical excellence.
Publisher: UNIV GADJAH MADA, FAC FARMASIISSN: 2338-9486Frequency: 4 issues/year

Indonesian Journal of Pharmacy (ISSN: 2338-9486; E-ISSN: 2338-9427), published by UNIV GADJAH MADA, FAC FARMASI, stands as a significant platform for disseminating pioneering research in the field of pharmacy and pharmacology. Since its transition to an Open Access format in 2011, the journal has enhanced its visibility and accessibility, catering to a global audience of researchers, practitioners, and students. With a commendable Q3 category ranking in Pharmaceutical Science, Pharmacology, and Pharmacy for 2023, along with its respectable Scopus ranks, it provides valuable insights and advancements in the pharmaceutical sciences, particularly relevant to the Indonesian context and beyond. The journal not only supports the academic community but also contributes to the enhancement of healthcare practices through rigorous peer-reviewed publications. By fostering knowledge exchange and collaboration, the Indonesian Journal of Pharmacy aims to play a pivotal role in advancing research and development in pharmacy-related disciplines.

TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH

Elevating pharmaceutical discourse in tropical regions.
Publisher: PHARMACOTHERAPY GROUPISSN: 1596-5996Frequency: 2 issues/year

Tropical Journal of Pharmaceutical Research is an esteemed open-access platform dedicated to advancing the field of pharmaceutical sciences, published by the Pharmacotherapy Group in Nigeria. With an ISSN of 1596-5996 and open access established since 2002, this journal serves as a critical resource for researchers, professionals, and students seeking to disseminate and access high-quality research in both pharmaceutical science and pharmacology. Despite its ranking in the third quartile (Q3) for Pharmaceutical Science and the fourth quartile (Q4) in Pharmacology as of 2023, the journal continues to stand out with its commitment to fostering significant dialogue and innovation in the scientific community. Anchored at the University of Benin, Faculty of Pharmacy, the journal invites contributions that explore novel pharmaceutical research, clinical applications, and drug development, playing a vital role in addressing health challenges that are particularly relevant to tropical regions. Researchers can look forward to publishing their findings in a journal that not only promotes the sharing of knowledge but also enhances the scientific discourse within a rapidly evolving field.